Friedman Emil M, Warner Mark, Shum Sam C, Adair Fred
MannKind Corporation, One Casper Street, Danbury, CT
MannKind Corporation, One Casper Street, Danbury, CT.
PDA J Pharm Sci Technol. 2015 Mar-Apr;69(2):264-9. doi: 10.5731/pdajpst.2015.01019.
In-process tests are used between manufacturing steps to avoid the cost of further processing material that is apt to fail its final tests. Rapid microbiological methods that return simple negative or positive results are attractive in this context because they are faster than the compendial methods used at product release. However, using a single such test will not reliably detect barely unacceptable material (sensitivity) without generating an undesirable number of false rejections (poor specificity). We quantify how to achieve a balance between the risks of false acceptance and false rejection by performing multiple rapid microbiological methods and applying an acceptance rule. We show how the end user can use a simple (and novel) graph to choose a sample size, the number of samples, and an acceptance rule that yield a good balance between the two risks while taking cost (number of tests) into account.
In-process tests are used between manufacturing steps to avoid the cost of further processing material that is apt to fail its final tests. Rapid microbiological methods that return simple negative or positive results are attractive in this context because they are faster than the compendial methods used at product release. However, using a single such test will not reliably detect barely unacceptable material (sensitivity) without generating an undesirable number of false rejections (poor specificity). We quantify how to achieve a balance between the risks of false acceptance and false rejection by performing multiple rapid microbiological methods and applying an acceptance rule. We show how the end user can use a simple (and novel) graph to choose a sample size, the number of samples, and an acceptance rule that yield a good balance between the two risks while taking cost (number of tests) into account.
在生产步骤之间使用过程中测试,以避免对可能无法通过最终测试的材料进行进一步加工的成本。在这种情况下,能给出简单阴性或阳性结果的快速微生物学方法很有吸引力,因为它们比产品放行时使用的药典方法更快。然而,仅使用单一此类测试无法可靠地检测出勉强不合格的材料(灵敏度问题),同时还会产生过多不理想的误判(特异性差)。我们通过执行多种快速微生物学方法并应用验收规则,来量化如何在误判接受和误判拒绝的风险之间取得平衡。我们展示了最终用户如何使用一个简单(且新颖)的图表来选择样本量、样本数量以及验收规则,在考虑成本(测试次数)的同时,在两种风险之间实现良好的平衡。
在生产步骤之间使用过程中测试,以避免对可能无法通过最终测试的材料进行进一步加工的成本。在这种情况下,能给出简单阴性或阳性结果的快速微生物学方法很有吸引力,因为它们比产品放行时使用的药典方法更快。然而,仅使用单一此类测试无法可靠地检测出勉强不合格的材料(灵敏度问题),同时还会产生过多不理想的误判(特异性差)。我们通过执行多种快速微生物学方法并应用验收规则,来量化如何在误判接受和误判拒绝的风险之间取得平衡。我们展示了最终用户如何使用一个简单(且新颖)的图表来选择样本量、样本数量以及验收规则,在考虑成本(测试次数)的同时,在两种风险之间实现良好的平衡。